<- Go Home
Dermapharm Holding SE
Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally. The company operates through three segments: Branded Pharmaceuticals, Other Healthcare Products, and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company also provides vitamins, minerals, food supplements, as well as products for dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology. In addition, it offers cosmetics and medical devices. Further, the company imports originator pharmaceuticals under the axicorp brand. It sells its products under the Dekristol, Keltican, Tromcardin, Ketozolin, bite away, and Herpotherm brands. The company was founded in 1991 and is based in Grünwald, Germany. Dermapharm Holding SE is a subsidiary of Themis Beteiligungs-AG.
Market Cap
EUR 1.8B
Volume
25.9K
Cash and Equivalents
EUR 162.7M
EBITDA
EUR 267.3M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
EUR 766.3M
Profit Margin
63.77%
52 Week High
EUR 42.50
52 Week Low
EUR 30.15
Dividend
N/A
Price / Book Value
2.96
Price / Earnings
16.85
Price / Tangible Book Value
-3.87
Enterprise Value
EUR 1.6B
Enterprise Value / EBITDA
5.98
Operating Income
EUR 240.5M
Return on Equity
18.23%
Return on Assets
6.92
Cash and Short Term Investments
EUR 162.7M
Debt
N/A
Equity
EUR 605.5M
Revenue
EUR 1.2B
Unlevered FCF
EUR 253.4M
Sector
Pharmaceuticals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium